On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- GLP-1s linked to better IBD outcomes, hinting at role as ‘valuable adjunctive therapies’ (Healio)
- The cyber siege of private practices: Are you at risk? (Medical Economics)
- Is The Galleri Cancer Test Worth It? A Doctor Explains (Forbes)
- With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists (GI & Hepatology News)
- The GI innovations transforming outcomes (Becker’s GI & Endoscopy)
- The Smart Toilet: Turning Waste Into Health Insights – Dr. Sonia Grego, Ph.D. (Progress, Potential, and Possibilities | YouTube)
- Peripheral gaze guidance improves adenoma detection rate (GI & Hepatology News)
- Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus (American Journal of Gastroenterology)
